S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Menlo Therapeutics Inc (MNLO)
Menlo Therapeutics Inc (MNLO) Financials

Menlo Therapeutics Inc (MNLO)

1.35

0.00

(0.00%)

At close: November 27 3:00PM

Delayed by 15 minutes

1.35

0.00

( 0.00% )

After Hours: -

Delayed by 15 minutes

Menlo Therapeutics Inc Financial Summary

The current MNLO market cap is 18.84M. The company's latest EPS is USD -2.0385 and P/E is -1.45.

Income Statement

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	135k	114k	76k	98k	198k
Operating Income	-10.32M	-6.23M	-6.83M	-7.38M	-10.4M
Net Income	-10.06M	-6.58M	-6.19M	-6.25M	-9.41M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	20.99M	14.76M	477k	424k
Operating Income	-76.24M	-198.2M	-68.03M	-34.3M	-29.26M
Net Income	-73.7M	-255.83M	-73.33M	-23.21M	-28.45M

Balance Sheet

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	24.96M	19.27M	97.69M	91.68M	86.65M
Total Liabilities	7.69M	7.76M	8.95M	8.31M	11.78M
Total Equity	17.27M	11.51M	88.74M	83.37M	74.87M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	79.17M	93.74M	67.05M	40.76M	97.69M
Total Liabilities	10.66M	56.25M	18.41M	9.35M	8.95M
Total Equity	68.51M	37.49M	48.64M	31.2M	88.74M

Cash Flow

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-15.05M	-20.2M	-25.34M	-7.98M	-16.46M
Investing	5M	5M	-57.35M	-3.57M	15.45M
Financing	-222k	-269k	82.39M	-4k	-7k

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-65.1M	-137.08M	-56.37M	-29.2M	-25.34M
Investing	41.37M	89.11M	1.03M	15.67M	-57.35M
Financing	4.99M	61.81M	39.78M	1.65M	82.39M

Stats and Ratios

Market Cap	18.84M
Price to Earnings Ratio	-1.45
Price to Sales Ratio	97.37
Price to Cash Ratio	1.35
Price to Book Ratio	0.47
Dividend Yield	-

Share Statistics

Shares Outstanding	13.96M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-
Spread (Intraday)	0.01 (0.73%)

Company Info

Company Name	Menlo Therapeutics Inc
Address	1521 concord pike suite 201 wilmington, delaware 19810
Website	https://vynetherapeutics.com
Industry	pharmaceutical preparations (2834)

Menlo Therapeutics

AFN vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions